microRNA for Clinical Research and Tumor Analysis
Transcript of microRNA for Clinical Research and Tumor Analysis
![Page 1: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/1.jpg)
Presented for:
Presented by:
Date:
microRNA
![Page 2: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/2.jpg)
2
![Page 3: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/3.jpg)
microRNAs
• Non protein coding, endogenous RNAs of 21-22nt length
• Evolutionarily conserved
• Regulate gene expression by binding complementary regions at 3’ regions of target mRNAs
• Act as negative regulators of gene expression
• miRNA expression profile is tissue specific
3
![Page 4: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/4.jpg)
miRNA functions
• Regulate 30% of coded genes
• Bring about translation inhibition and mRNA cleavage
• A part of the miRNA matches the target mRNA
• The greater the degree of complimentarity with the target mRNA, greater is the probability of mRNA degradation
4
![Page 5: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/5.jpg)
Diversity of miRNA functions
5
• Development
• Timing
• Cell proliferation
• Stem cell
• Cell death
• DNA methylation and chromatin formation
• Diseases
• Cancer
• Diabetes
• Cholesterol biosynthesis
• Nervous system disorders
• Autoimmune diseases
• Metabolic diseases
![Page 6: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/6.jpg)
microRNAs
6
microRNAs
Aging and Apoptosis
Metabolism
Viral Infection
Tumourigenesis
Development / Differentiation
![Page 7: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/7.jpg)
miRNA and Cancer
7
http://dx.doi.org/10.1038/nature10888
• Majority of miRNA genes are located in cancer associated regions and chromosome fragile sites
• Indicate a differential expression pattern in normal and tumor tissues
• miRNA display tissue and cell lineage specificity
• Altered miRNA expression pattern can serve as markers for
• Tumor diagnosis
• Disease prognosis
• Therapeutic response prediction
• Cancer of unknown primary
![Page 8: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/8.jpg)
8
microRNAs: Oncogene / Tumor Suppressor
Tumor Suppressor
Oncogene
Oncogenic miRNAs:
Tumor suppressor miRNAs:
Tumor
Normal cell
miR-17-92 Pten
let-7 Ras
![Page 9: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/9.jpg)
miRNAs: Oncogene / Tumor Suppressor
9
Cancer Type Human microRNA Potential Function
Breast Cancer miR-21, miR-125b; miR126, miR-206, miR-335
OncomiR; Metastasis Suppressor
Colon Cancer miR-21; miR-34a OncomiR; Tumor Suppressor
Lung Cancer miR-21, miR17-92 cluster, miR-106b/93/25 cluster; Let-7a, miR-143, miR-145
OncomiR; Tumor Suppressor
Pancreatic Cancer miR-196a, miR196b OncomiR
Prostate Cancer miR-21, miR-15/16; miR145, miR-146, miR-330, miR205
OncomiR; Tumor Suppressor
Ovarian Cancer miR-141, miR-200a/b/c; miR-199a/b, miR-140, miR-145, miR-204, miR125a/b,
OncomiR; Tumor Suppressor
Hepatocellular Carcinoma
miR-21, miR-224, miR34a, miR221, miR-222, miR-106, miR-303; miR26a/b, let-7g, miR-122, miR-422b, miR-145, miR-199
OncomiR; Tumor Suppressor; Metastasis
Thyroid Cancer miR-146, miR-221, miR222, miR-181b, miR-155, miR224
OncomiR
![Page 10: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/10.jpg)
miRNA & Cancer of Unknown Primary (CUP)
• Malignant cancers whose origins cannot be identified based on
• Clinical history
• Complete physical examination
• Routine laboratory tests
• Imaging and radio metabolic techniques
• Histological analysis
• Accounts for 3-5% of all cancers
• The prognosis of patients with CUP is poor with a median survival of 4-12 months
10
![Page 11: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/11.jpg)
miRNA & Cancer of Unknown Primary (CUP)
• Present treatment is based on consideration for the cell type
• This leads to reduced antineoplastic efficacy and poor outcome.
• miRNA based classification gave 90% accuracy in classifying cancers of unknown primary
• Classification based on differential expression of miRNA that correlated with cancer type, stage and clinicopathological variables
• Provides superior classification of CUP when compared with classification based on mRNA
11
![Page 12: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/12.jpg)
miRNAs as diagnostic markers
12
Utilizing a signature of altered miRNA expression to differentiate cancer tissue from normal tissue
Profiling circulating blood or tumor derived exosomal miRNAs, surpassing the invasive procedures to aid in early detection of cancers
Study SNPs in the miRNA genes, miRNA binding sites in the target mRNA genes or in the miRNA processing/ machinery pathway genes to predict cancer predisposition
Use of miRNA based classifier to identify tissue of origin for cancers of unknown primaries
Distinguishing tumor subtypes using a panel of miRNAs that show differential expression within one cancer type
MicroRNAs
in
Cancer
Diagnosis
MicroRNAs: tools for cancer diagnostics. Gut 2009;58:1546–1554. doi:10.1136/gut.2009.179531
![Page 13: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/13.jpg)
miRNA Analysis
13
Microarray qRT-PCR
RNase protection assay Northern blot
![Page 14: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/14.jpg)
miRNAs in Situ Hybridization
• Larger scale analysis of miRNAs is required for fully understanding their biologicalfunctions within disease setting. FFPE tissue samples are invaluable source forthis study.
• Study the macroscopic distribution and cellular localization of miRNAs in aheterogeneous cell population.
• Several technique problems in miRNAs in situ hybridization: RNA integrity, lowerconcentration, very short RNA nucleotides, protection from associated proteinsand cellular structure.
14
![Page 15: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/15.jpg)
15
microRNAs are Stable in FFPE Tissues
Li et al. BMC Biotechnol. 2007; 7: 36. 2
Xi et al. 2007 RNA 13:1-7
Year
![Page 16: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/16.jpg)
16
microRNAs are Stable in FFPE Tissues
Li et al. BMC Biotechnol. 2007; 7: 36. 2
Xi et al. 2007 RNA 13:1-7
Year
![Page 17: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/17.jpg)
17
Workflow for MicroRNA Detection
Probes labeled
with BioGenex
5’-Fluorescein
miR-21 miR-21 & p53
Adding miRNA Probes
Deparaffinization and Pretreatment
BioGenex miRNA Detection Systems
Loading Slides
![Page 18: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/18.jpg)
miRNA Analysis - ISH
• miRNA’s are well preserved in FFPE and frozen samples
• Can be exploited to understand their role in diseases
• Allows to study macroscopic distribution and cellular localization of miRNA in a heterogeneous population
18
![Page 19: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/19.jpg)
miRNA in-situ hybridization work flow
19
Dewaxing Proteinase K
treatment Labeled miRNA
Probe incubation Stringent Buffer
wash
Peroxide Block and Power Block
Anti-fluorescein antibody
Secondary antibody
(Polymer HRP) Chromogen
Clearing and Mounting
Hematoxylin counter stain
![Page 20: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/20.jpg)
miRNA as Therapeutic Targets
• OncomiRs can act as targets for down regulation
• Can be targeted by anti-sense nucleotides to bring about anti-cancer effect
• Timor suppressive miRNAs can be upregulated to inhibit tumor progression
20
![Page 21: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/21.jpg)
Biogenex miRNA probes I
21
A
B
C
A. Has-miR-1
B. Has-miR-21
C. Has-miR-146a
A
B
A. Has-miR-145
B. Has-miR-205
C. miR-145 mutant C
![Page 22: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/22.jpg)
Biogenex miRNA probes II
22
A. Has-miR-328
B. SnRNA U6
C. Has-miR-221
A. Has-miR-146 +anti-p53
B. Has-miR-222
A
B
A
C
B
![Page 23: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/23.jpg)
One Step ISH detection Kit
23
• BioGenex has launched in-situ detection of microRNAs in FFPE tissues on fully automated Xmatrx system.
• It offers the following advantages:
• Complete kit with all reagents needed, we also offer positive
• (snRNA U6 probe) and negative (Scramble sequence) probes
• Biotin-free system to avoid endogenous biotin activity.
• Poly-HRP detection system provides higher sensitivity.
• Can be combined with IHC to co-detect miRNA and protein biomarkers.
![Page 24: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/24.jpg)
24
One Step ISH detection Kit
![Page 25: microRNA for Clinical Research and Tumor Analysis](https://reader031.fdocuments.us/reader031/viewer/2022030211/58a2a0de1a28ab0d0a8b5271/html5/thumbnails/25.jpg)
Pleasevisitwww.biogenex.comformoredetailsonourproductpor8olio